ITMCTR1900002341
Not yet recruiting
Phase 1
Clinical study for diagnostic markers in cerebrospinal fluid of Alzheimer's disease
The Third Affiliated Hospital of Zhejiang Chinese Medical University0 sitesTBD
ConditionsAlzheimer's disease
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Alzheimer's disease
- Sponsor
- The Third Affiliated Hospital of Zhejiang Chinese Medical University
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged\>\=60 years old;
- •2\. Meet the diagnostic criteria of clinical typical AD;
- •3\. Specific clinical phenotype, early and significant episodic memory impairment (isolated or other cognitive, behavioral changes associated with implicated dementia syndrome or mild cognitive impairment), including the following characteristics:
- •(1\) The patient or the insider complains that the memory ability has gradually declined over 6 months;
- •(2\) The objective evidence of the hippocampus type amnesia syndrome, based on the AD\-specific detection method\-\-through the clue recall test, found that the episodic memory ability decreased significantly, according to the simple intelligent mental state checklist MMSE diagnostic criteria: illiterate group \= 17 points, primary school group \= 20 points, middle school or above group \= 24 points (heavy disease in moderate stage dementia stage hippocampus amnesia syndrome may be difficult to identify, in vivo AD pathological evidence is sufficient to exist in the characteristics of dementia syndrome: cerebrospinal fluid Aß42 reduction, bilateral frontal apical area glucose radioactivity Counting drops significantly).
Exclusion Criteria
- •1\. Severe hemodynamic instability and unstable vital signs;
- •2\. Malignant arrhythmia, severe failure of organ function such as heart, lung, liver and kidney, suffering from tumor;
- •3\. Cognitive impairment cannot be matched with lumbar puncture;
- •4\. Participated in other clinical studies within 2 months prior to the start of the study;
- •5\. The patient or his licensor is unwilling to sign a written informed consent or is unwilling to follow the research protocol;
- •6\. Other types of dementia:
- •(1\) sudden onset;
- •(2\) Early symptoms: gait disorder, epilepsy, behavioral changes.
- •Clinical features:
- •(1\) focal neurological features;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Assessment of clinical neurophysiological biomarkers for the differentiation of neurodegenerative disease versus non-neurological disorder in patients with mild cognitive impairment.cognitive disordersintellectual disabilitymild cognitive impairmentNL-OMON56487Centre for Human Drug Research30
Recruiting
Not Applicable
Investigation of neurophysiological marker in internet game addictioMental and behavioral disordersKCT0001849Seoul Metropolitan Government Seoul National University Boramae Medical Center750
Completed
Not Applicable
Biomarkers in Neural DisordersParkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear PalsyEssential TremorMultiple System AtrophyDrug Induced Parkinson's DiseaseDiffuse Lewy Body DiseaseMyasthenia GravisSpinal Cord InjuriesNCT02761707University of Pennsylvania54
Recruiting
Not Applicable
Validation of cerebral blood flow-related biomarkers for neurodegenerative disease at an early stageAlzheimerAlzheimer's disease10029305NL-OMON49623eurologie - Alzheimer Centrum355
Not yet recruiting
Not Applicable
Assessing the functional outcome of the spinal tumour surgeryCTRI/2024/02/063352ational Institute of Mental Health and Neuro Sciences NIMHANS